| AGENCY: HHS-ACF | RIN: 0970-AD34 | Status: Pending Review for rule 0970-AD34 | Request EO Meeting for rule 0970-AD34 |
| TITLE: Unaccompanied Alien Children Program Foundational Rule; Updates to Accord with the Hyde Amendment | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 01/23/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-ACF | RIN: 0970-AD47 | Status: Pending Review for rule 0970-AD47 | Request EO Meeting for rule 0970-AD47 |
| TITLE: Ensuring Program Integrity for Head Start Programs | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 08/05/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-ACF | RIN: 0970-AD43 | Status: Pending Review for rule 0970-AD43 | Request EO Meeting for rule 0970-AD43 |
| TITLE: Unaccompanied Alien Children Bureau Reunification of Certain Unaccompanied Alien Children with a Parent or Legal Guardian in a Country Other Than the United States | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 08/07/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-ACF | RIN: 0970-AD49 | Status: Pending Review for rule 0970-AD49 | Request EO Meeting for rule 0970-AD49 |
| TITLE: Reducing Bureaucracy and Burden for Block Grants | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 09/03/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-ACF | RIN: 0970-AD21 | Status: Pending Review for rule 0970-AD21 | Request EO Meeting for rule 0970-AD21 |
| TITLE: Restoring Flexibility to Support Head Start Program Access | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 09/10/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-ACF | RIN: 0970-AD45 | Status: Pending Review for rule 0970-AD45 | Request EO Meeting for rule 0970-AD45 |
| TITLE: Reducing Bureaucracy and Burden in Part 1370 | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 09/15/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-ACF | RIN: 0970-AD29 | Status: Pending Review for rule 0970-AD29 | Request EO Meeting for rule 0970-AD29 |
| TITLE: Reducing Bureaucracy and Burden in the Child Care and Development Fund (CCDF) | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 09/17/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-ACF | RIN: 0970-AD39 | Status: Pending Review for rule 0970-AD39 | Request EO Meeting for rule 0970-AD39 |
| TITLE: Reducing Bureaucracy and Burden for Child Support Enforcement | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 09/28/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-CMS | RIN: 0938-AW03 | Status: Pending Review for rule 0938-AW03 | Request EO Meeting for rule 0938-AW03 |
| TITLE: Exchange Pre-Enrollment Eligibility Verification (CMS-9873) | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 04/22/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-CMS | RIN: 0938-AV70 | Status: Pending Review for rule 0938-AV70 | Request EO Meeting for rule 0938-AV70 |
| TITLE: Strengthening the Integrity of Medicaid and CHIP Managed Care, Financing, and Access to Care (CMS-2450) | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 05/12/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-CMS | RIN: 0938-AV92 | Status: Pending Review for rule 0938-AV92 | Request EO Meeting for rule 0938-AV92 |
| TITLE: Short-Term, Limited-Duration Insurance (CMS-9881) | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 05/30/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-CMS | RIN: 0938-AV74 | Status: Pending Review for rule 0938-AV74 | Request EO Meeting for rule 0938-AV74 |
| TITLE: Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model (CMS-5546) | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 06/15/2026 | LEGAL DEADLINE: Statutory | ||
| AGENCY: HHS-CMS | RIN: 0938-AW04 | Status: Pending Review for rule 0938-AW04 | Request EO Meeting for rule 0938-AW04 |
| TITLE: Cutting Administrative Requirements for Excellence in Patient Care (CMS-3484) | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 07/02/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-CMS | RIN: 0938-AV99 | Status: Pending Review for rule 0938-AV99 | Request EO Meeting for rule 0938-AV99 |
| TITLE: Patient Protection and Affordable Care Act; State Innovation Waivers and Health Care Choice Compacts (CMS-9877) | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 07/13/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-CMS | RIN: 0938-AV97 | Status: Pending Review for rule 0938-AV97 | Request EO Meeting for rule 0938-AV97 |
| TITLE: Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) (CMS-6098) | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 08/07/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-CMS | RIN: 0938-AU54 | Status: Pending Review for rule 0938-AU54 | Request EO Meeting for rule 0938-AU54 |
| TITLE: Amendments to Rules Governing Organ Procurement Organizations (CMS-3409) | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 08/20/2026 | LEGAL DEADLINE: Statutory | ||
| AGENCY: HHS-CMS | RIN: 0938-AV90 | Status: Pending Review for rule 0938-AV90 | Request EO Meeting for rule 0938-AV90 |
| TITLE: Medicare Drug Price Negotiation Program (CMS-4215) | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 09/09/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-CMS | RIN: 0938-AV81 | Status: Pending Review for rule 0938-AV81 | Request EO Meeting for rule 0938-AV81 |
| TITLE: CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System and Quality Incentive Program (CMS-1846) | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 09/17/2026 | LEGAL DEADLINE: Statutory | ||
| AGENCY: HHS-CMS | RIN: 0938-AV83 | Status: Pending Review for rule 0938-AV83 | Request EO Meeting for rule 0938-AV83 |
| TITLE: CY 2027 Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates (CMS-1850) | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 09/17/2026 | LEGAL DEADLINE: Statutory | ||
| AGENCY: HHS-CMS | RIN: 0938-AV80 | Status: Pending Review for rule 0938-AV80 | Request EO Meeting for rule 0938-AV80 |
| TITLE: CY 2027 Home Health Prospective Payment System Rate Update and Home Infusion Therapy Services Payment Update (CMS-1844) | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 09/21/2026 | LEGAL DEADLINE: Statutory | ||
| AGENCY: HHS-CMS | RIN: 0938-AV82 | Status: Pending Review for rule 0938-AV82 | Request EO Meeting for rule 0938-AV82 |
| TITLE: CY 2027 Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Medicare Part B (CMS-1848) | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 09/29/2026 | LEGAL DEADLINE: Statutory | ||
| AGENCY: HHS-CMS | RIN: 0938-AW00 | Status: Pending Review for rule 0938-AW00 | Request EO Meeting for rule 0938-AW00 |
| TITLE: Expanding Access to Individual Coverage Health Reimbursement Arrangements (CMS-9876) | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 10/05/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-ZC82 | Status: Pending Review for rule 0910-ZC82 | Request EO Meeting for rule 0910-ZC82 |
| TITLE: Cannabidiol (CBD) Products Compliance and Enforcement Policy | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 03/13/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-AJ03 | Status: Pending Review for rule 0910-AJ03 | Request EO Meeting for rule 0910-AJ03 |
| TITLE: Requirements For Additional Traceability Records For Certain Foods: Compliance Date Extension | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 06/03/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-AI05 | Status: Pending Review for rule 0910-AI05 | Request EO Meeting for rule 0910-AI05 |
| TITLE: Administrative Detention of Tobacco Products | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 07/09/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-ZD48 | Status: Pending Review for rule 0910-ZD48 | Request EO Meeting for rule 0910-ZD48 |
| TITLE: U.S.-Origin Statements on Seafood; Draft Guidance for Industry | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 07/10/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-ZD60 | Status: Pending Review for rule 0910-ZD60 | Request EO Meeting for rule 0910-ZD60 |
| TITLE: White Paper: Proposed Definition of Ultra-Processed Food | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 08/03/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-AI83 | Status: Pending Review for rule 0910-AI83 | Request EO Meeting for rule 0910-AI83 |
| TITLE: Use of Formaldehyde and Formaldehyde-Releasing Chemicals as an Ingredient in Hair Smoothing Products or Hair Straightening Products | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 08/06/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-AI42 | Status: Pending Review for rule 0910-AI42 | Request EO Meeting for rule 0910-AI42 |
| TITLE: Cheeses and Related Cheese Products; Proposal to Permit the Use of Ultrafiltered Milk and Microfiltered Milk | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 08/28/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-AG30 | Status: Pending Review for rule 0910-AG30 | Request EO Meeting for rule 0910-AG30 |
| TITLE: Sunlamp Products; Amendment to the Performance Standard | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 09/09/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-ZD68 | Status: Pending Review for rule 0910-ZD68 | Request EO Meeting for rule 0910-ZD68 |
| TITLE: Validation of Certain In Vitro Diagnostic Devices for Emerging Pathogens During a Section 564 Declared Emergency; Guidance for Industry and Food and Drug Administration Staff; Availability | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 09/10/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-ZD81 | Status: Pending Review for rule 0910-ZD81 | Request EO Meeting for rule 0910-ZD81 |
| TITLE: Potency Assurance for Cellular and Gene Therapy Products; Guidance for Industry; Availability | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 09/17/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-ZD84 | Status: Pending Review for rule 0910-ZD84 | Request EO Meeting for rule 0910-ZD84 |
| TITLE: Clinical Trial Enrollment Action Plans to Improve Representation of the U.S. Intended Use Population in Clinical Studies | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 10/06/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-AJ34 | Status: Pending Review for rule 0910-AJ34 | Request EO Meeting for rule 0910-AJ34 |
| TITLE: Infant Formula Nutrient Requirements | |||
| STAGE: Proposed Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 10/14/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-ZD94 | Status: Pending Review for rule 0910-ZD94 | Request EO Meeting for rule 0910-ZD94 |
| TITLE: Interim Access Policy for Compounding Using Certain Peptides | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 10/14/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-FDA | RIN: 0910-ZD95 | Status: Pending Review for rule 0910-ZD95 | Request EO Meeting for rule 0910-ZD95 |
| TITLE: Patient-level data for drugs and biological products submissions containing real-world data and real-world evidence; Request for Information | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| ** RECEIVED DATE: 10/15/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-NIH | RIN: 0925-ZA21 | Status: Pending Review for rule 0925-ZA21 | Request EO Meeting for rule 0925-ZA21 |
| TITLE: 2026 NIH Research Plan on Rehabilitation | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 09/11/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-NIH | RIN: 0925-ZA22 | Status: Pending Review for rule 0925-ZA22 | Request EO Meeting for rule 0925-ZA22 |
| TITLE: Request for Information: Developing Menopause Common Data Elements | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 09/28/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-NIH | RIN: 0925-ZA25 | Status: Pending Review for rule 0925-ZA25 | Request EO Meeting for rule 0925-ZA25 |
| TITLE: Draft Policy Update to the NIH Policy for Data and Safety Monitoring Request for Information | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 09/29/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-NIH | RIN: 0925-ZA26 | Status: Pending Review for rule 0925-ZA26 | Request EO Meeting for rule 0925-ZA26 |
| TITLE: Request for Information: Seeking New and Emerging Areas of Science Relevant to the NIDCD Mission, To Inform an Update of the NIDCD Strategic Plan for 2028-2032 | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 10/01/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-NIH | RIN: 0925-ZA27 | Status: Pending Review for rule 0925-ZA27 | Request EO Meeting for rule 0925-ZA27 |
| TITLE: National Institute on Aging Strategic Directions 2026-2030 | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 10/02/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-NIH | RIN: 0925-ZA28 | Status: Pending Review for rule 0925-ZA28 | Request EO Meeting for rule 0925-ZA28 |
| TITLE: Minority Health and Health Disparities Research Strategic Plan Fiscal Years 2026-2030 | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 10/06/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-NIH | RIN: 0925-ZA29 | Status: Pending Review for rule 0925-ZA29 | Request EO Meeting for rule 0925-ZA29 |
| TITLE: Notice of Change: Updates to SBIR and STTR Foreign Risk Notification and Mitigation Process | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| ** RECEIVED DATE: 10/15/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-OCR | RIN: 0945-AA00 | Status: Pending Review for rule 0945-AA00 | Request EO Meeting for rule 0945-AA00 |
| TITLE: HIPAA Privacy Rule: Changes to Support Coordinated Care and Individual Engagement and Reduce Regulatory Burdens | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 04/02/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-OCR | RIN: 0945-AA27 | Status: Pending Review for rule 0945-AA27 | Request EO Meeting for rule 0945-AA27 |
| TITLE: Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 09/30/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-ONC | RIN: 0955-AA09 | Status: Pending Review for rule 0955-AA09 | Request EO Meeting for rule 0955-AA09 |
| TITLE: Health Data, Technology, and Interoperability: ASTP/ONC Deregulatory Actions to Unleash Prosperity | |||
| STAGE: Final Rule | ECONOMICALLY SIGNIFICANT: Yes | ||
| RECEIVED DATE: 07/28/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-SAMHSA | RIN: 0930-AA40 | Status: Pending Review for rule 0930-AA40 | Request EO Meeting for rule 0930-AA40 |
| TITLE: Mandatory Guidelines for Federal Workplace Drug Testing Programs using Urine (UrMG) | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 06/11/2026 | LEGAL DEADLINE: None | ||
| AGENCY: HHS-SAMHSA | RIN: 0930-AA41 | Status: Pending Review for rule 0930-AA41 | Request EO Meeting for rule 0930-AA41 |
| TITLE: Mandatory Guidelines for Federal Workplace Drug Testing Programs using Oral Fluid (OFMG) | |||
| STAGE: Notice | ECONOMICALLY SIGNIFICANT: No | ||
| RECEIVED DATE: 06/11/2026 | LEGAL DEADLINE: None | ||